Molecular detection and characterization of human gyroviruses identified in the ferret fecal virome. by Fehér, Enikő et al.
1 
 
Title: Molecular detection and characterization of human gyroviruses identified in the ferret fecal virome 
 
Authors: 
1 Enikő Fehér, 2 Péter Pazár, 1 Eszter Kovács, 1 Szilvia L Farkas, 3 György Lengyel, 4 Ferenc Jakab, 5 Vito 
Martella, 
1 
Krisztián Bányai 
 
Author affiliations: 
1
 Institute for Veterinary Medical Research, Centre for Agricultural Research, Hungarian Academy of Sciences, 
Hungária krt. 21, H-1143 Budapest, Hungary 
2
 Department and Clinic of Internal Medicine, Faculty of Veterinary Sciences, Szent István University, István 
utca 2, H-1078 Budapest, Hungary 
3
 Hungarian Defence Forces, Military Medical Centre, Róbert Károly krt. 44, H-1134 Budapest, Hungary 
4
 Virological Research Group, Szentágothai Research Center, University of Pécs, Ifjúság útja 20, H-7623 Pécs, 
Hungary 
5
 Department of Public Health and Animal Sciences, University of Bari, S.p. per Casamassima km 3, 70010, 
Valenzano, Bari, Italy 
 
Corresponding author: 
Enikő Fehér, Institute for Veterinary Medical Research, Centre for Agricultural Research, Hungarian Academy 
of Sciences, Hungária krt. 21, H-1143 Budapest, Hungary; e-mail: feher.eniko@agrar.mta.hu, Tel.: +36 1 467 
4060, Fax: +36 1 467 4076 
Abstract 
 
The recently described novel gyroviruses may infect chickens and/or humans, however, their 
pathogenic potential is unknown. In our metagenomic investigation we detected many of the novel gyroviruses 
in the fecal viromes of ferrets with lymph node and organ enlargement. The whole genomic sequences of 
selected gyrovirus strains showed 90.7-99.4% similarity with homologous reference gyrovirus strains. This study 
does not elucidate an association between gyrovirus shedding of ferrets and the observed background disease; 
however, it provides evidence for genetic diversity within gyroviruses and raises the possibility that pet ferrets 
may transmit gyroviruses to heterologous hosts, e.g. humans. 
Manuscript
Click here to download Manuscript: 20140623_MS_Feher.doc 
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
Several new members of the genus Gyrovirus (family Circoviridae) have been described during the past 
three years. Chicken anaemia virus (CAV) causes anaemia, bone marrow atrophy and severe 
immunosuppression in poultry, and represents the prototype species within the genus. Newly described members 
include human gyrovirus (HGyV), avian gyrovirus 2 (AGV2), GyV3, GyV4, GyV5 and GyV6 [1-5]. Of interest, 
some of these new gyrovirus types have been identified in human skin (HGyV), blood (HGyV) and stool (all 
gyroviruses) specimens, although the etiologic role of these viruses in a human disease has not been revealed [1-
7]. Furthermore, in addition to CAV, AGV2, HGyV and GyV4 have been also detected in chicken serum, meat 
and skin [1-3]. 
 In this study, 23 diarrheic stool specimens were collected from 20 pet ferrets (Mustela putorius furo) 
housed in a shelter. The animals had a background disease characterized by lymph node and spleen enlargement. 
The majority of samples (21 samples of 18 ferrets) were subjected to viral metagenomics. In brief, the genomic 
RNA was extracted using the Viral RNA Mini kit (QIAGEN) according to the manufacturer's instructions. The 
RNA sample was denatured at 97°C for 5 min in the presence of 10 µM random hexamer tailed by a common 
PCR primer sequence [8]. Reverse transcription reaction mixture containing 400 µM dNTPs, 1X AMV RT 
buffer and 1 U AMV reverse transcriptase (Promega) was added and then incubated at 42°C for 45 min. 5 µl 
cDNA was amplified in a final reaction volume of 50 µl including 500 µM PCR primers, 200 µM dNTP 
mixture, 1.5 mM MgCl2, 1X Taq DNA polymerase buffer and 0.5 U Taq DNA polymerase (Thermo Scientific). 
The reaction conditions consisted of a denaturation step at 95°C for 3 min, 40 cycles of amplification (95°C for 
30 sec, 48°C for 30 sec, 72°C for 2 min) and a final extension step at 72°C for 8 min. 
Enzymatic fragmentation was carried out from 100 ng of the amplified cDNA using the reagents of the 
NEBNext® Fast DNA Fragmentation & Library Prep Set for Ion Torrent™ kit (New England Biolabs) 
according to the manufacturer's instruction. The adaptor ligation was performed with reagents from the same kit, 
whereas barcoded adaptors were retrieved from the Ion XpressTM Barcode Adapters (Life Technologies). The 
barcoded library DNA samples were column extracted using the Gel/PCR DNA Fragments Extraction kit kit 
(Geneaid) and then run on 2% precast gel (Life Technologies). Products between 300 and 350 bp were directly 
used without further purification in the PCR mixture of the NEBNextR Fast DNA Fragmentation & Library Prep 
Set for Ion Torrent
TM
 kit (NEB). Library DNA was subsequently amplified (initial denaturation at 98° C for 30 
sec, followed by 12 amplification cycles of 98°C for 10 sec, 58°C for 30 sec and 72°C for 30 sec, and terminated 
at 72°C for 5 min). The amplified library DNA was purified by the Gel/PCR DNA Fragments Extraction kit 
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(Geneaid) and was quantified fluorimetrically on a Qubit® 2.0 equipment using the Qubit® dsDNA BR Assay 
kit (Life Technologies). Approximately equimolar aliquots of the individually barcoded products were mixed in 
a single tube and this library mixture was used in subsequent emulsion PCR according to the manufacturer's 
protocol using the Ion PGM Template kit on an OneTouch v2 instrument. Enrichment of the templated beads (on 
an Ion One Touch ES machine) and further steps of pre-sequencing set-up were performed according to the 200 
bp sequencing protocol of the manufacturer (Life Technologies). The sequencing protocol recommended for Ion 
PGM
TM
 Sequencing Kit on a 316 chip was strictly followed. Raw sequence data were mapped onto reference 
sequences of the GenBank in the CLC Bio software (http://www.clcbio.com/). Sequence alignments and distance 
matrixes using the p-distance algorithm were prepared in MEGA 6 using the MUSCLE program [9]. 
Viral metagenomics generated an average 67,737 sequence reads (range, 36,337-87,870) from each 
barcoded cDNA library. The metagenomic assemblage identified coronaviruses and a great diversity of 
gyroviruses (including HGyV, AGV2, GyV3, GyV4 and CAV; Table 1) in 50% (9/18) and 44% (8/18) of the 
animals, respectively. Although detection of chicken origin gyroviruses (such as CAV and AGV2) was not 
surprising in the fecal specimens, the identification of putative human gyroviruses in the ferret fecal virome was 
somewhat unexpected; therefore, we systematically screened by PCR all available ferret stool samples for 
different gyroviruses, including those that were previously found exclusively in humans, in chicken or both. 
The PCR primers targeted the VP1 gene of HGyV/AGV2, GyV3, GyV4 and CAV, and the VP2 
genomic region of HGyV/AGV2 and GyV3 [3-4]. When the results of targeted PCR and metagenomic analysis 
were merged, the stool samples of 14 animals were found to contain traces of the gyrovirus genomic DNA. The 
main type was HGyV (identified in 13 of 14 animals). Eleven animals shed a mixture of gyroviruses; CAV was a 
commonly seen strain in specimens containing multiple gyroviruses (11/11), whereas GyV3, GyV4 and AGV2 
were amplified by PCR from two, one and one ferrets, respectively. Of interest, genomic DNA of another GyV3 
and three GyV4 was identified by viral metagenomics in specimens negative by gene-specific PCR. Sequence 
variation in the primer binding region provided a possible explanation for PCR failures in some instances and 
suggested limited sensitivity of published GyV3 and GyV4 specific PCR primers [3-4].  
Subsequently, PCR primers were designed for the amplification of representative full-length gyrovirus 
genomes. PCR assays with back-to-back primers were performed in a reaction volume of 20 µl containing 250 
µM of each dNTPs, 250 nM of each primers, 1X Phusion Green HF Buffer and 0.3 U Phusion DNA polymerase 
(Thermo Scientific). Amplification conditions was as follows: denaturation at 98 ºC for 30 s denaturation, 40 
cycles of 98 ºC for 10s, 53 or 59 ºC for 30s (for GyV4 or HGyV/AGV2, respectively) and 72 ºC for 90 s, and a 
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final extension at 72 ºC for 10 min. Sequencing of the amplified genomes was performed with the ‘primer-
walking’ approach and Sanger sequencing by ABI PRISM® 3100-Avant Genetic Analyzer using BigDye 
Terminator v3.1 Cycle Sequencing Kit (Life Technologies). Primers used for amplification and sequencing are 
presented in Table 2. The full-length genomes of five ferret origin gyrovirus strains (three HGyV, one AGV2, 
one GyV4) were determined and three representative genome sequences were deposited in the GenBank 
(accession numbers: KJ452213 for AGV2 G17, KJ452214 for HGyV G13 and KJ452215 for GyV4 G14). Short 
fragments (~15-25 nucleotides in length) in the non-coding region could be sequenced only by a modified 
sequencing protocol due to the high GC content of the predicted hairpin structure just downstream the VP1, 
although, back-to-back and other primers designed to amplify smaller products (559 bp for HGyV and AGV2 
and 599 bp for Gyv4) spanning the putative hairpin structure worked well in our hands. Sequencing issues 
concerning these non-coding fragments even after cloning was reported by other research groups [5]. In the 
present study PCR assays and sequencing reactions in the presence of different concentrations of DMSO, betaine 
and Q-solution (Qiagen) were tested alike, but early termination of the sequencing reaction was always noticed 
(Fig. 1, Panel A). A modified PCR using 7-deaza-dGTP (New England Biolabs) in a reaction volume of 20 µl 
contained 250 nM of the primers specific to the GC-rich region (Table 1), 25 µM of dATP, dCTP, dTTP and 7-
deaza-dGTP (New England Biolabs), 1X DreamTaq Green Buffer and 0.5 U DreamTaq DNA Polymerase 
(Thermo Scientific). The cycling profile was as follows: denaturation at 95 ºC for 3 min, 40 cycles of 95 ºC for 
30 s, 54 ºC for 30 s and 72 ºC for 1 min, and a final extension step at 72 ºC for 10 min. Similarly to previous 
attempts these sequences were also terminated before reaching the GC-rich region or yielded ambiguous 
sequencing results (Fig. 1, Panel B). The only effective way to obtain high quality sequences for the hairpin 
region was when 2.5-5 µM 7-deaza-dGTP was included in both PCR and sequencing reaction mixtures (Fig. 1, 
Panel C). As a result alternating reiterations of homo-G-polymer and homo-C-polymer regions, 61 nt 
(HGyV/AGV2) and 42 nt (GyV4) in length, were revealed in the missing genomic region. 
The three HGyV genomes were 2375 nt long; the genome sequences were identical to each other, and 
were closely related (94.5%) to the AGV2 G17 strain having a genome of 2378 nt. The Hungarian HGyV G13 
whole genomic sequence was 61 nt longer than that of the reference HGyV (accession number: FR823283) 
which latter lacked the GC-rich region identified in our HGyV and AGV2 genomes as well as in the AGV2 
genomes deposited in the GenBank (accession numbers: JQ690763, HM590588). The complete genomes of 
HGyV G13 and AGV2 G17 showed 99.4% and 94.2-95.9% similarities along the overlapping regions of the 
whole genomes of homologous reference HGyV and AGV2 strains, respectively. Although the genome of the 
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G17 strain had a codon insertion affecting the potential VP2 and VP3 proteins, the whole genome size and the 
structure of the non-coding region was comparable with the G13 and the AGV2 reference genome sequences. 
The full-length genome of the Hungarian GyV4 strain, G14, was 2028 nt long, i.e. six bases shorter than 
the single known GyV4 reference genome available in the GenBank (accession number: JX310702). These two 
genome sequences showed 90.7% nt similarity to each other. The nt and amino acid similarities along the VP1 
and VP2 regions showed an inverse pattern (86.7% and 94% nt and 92.6% and 88.9% aa similarities, 
respectively) to the reference. This lower sequence similarity between GyV4 strains suggests a greater diversity 
within this group of gyroviruses than seen among HGyV and AGV2 strains, which latter are supposed to be 
minor sequence variants of the same virus [3].  
PCR results obtained by the diagnostic primers were systematically confirmed by sequencing of the 
amplicons. Briefly, the short HGyV sequences (251-429 nt long) amplified by the diagnostic primers [3-4] 
shared 100% identity among themselves. A 392 nt long stretch [3-4] of two GyV3 strains shared 98% nt 
sequence identities between themselves and 99% to the reference sequence (acession number: JQ308210). The 
only GyV4 sequence (239 nt long) amplified by diagnostic primers [3] showed 93.3% and 94.6% nt similarity 
with our (G14) and the reference GyV4 strain, respectively. CAV strains showed 99-100% similarities to each 
other and 100% similarity to the reference strains found in the GenBank. No traces of GyV5 and GyV6 were 
observed in the metagenomic analyses; thus the study was not extended to the examination of these novel 
gyroviruses. Unfortunately, determination of whole genomic sequences of additional gyroviruses was not 
possible because of the small amount of stool samples and/or the poor amplification results. 
 The identification of genetically related, actually indistinguishable, gyroviruses in the fecal viromes of 
humans and ferrets is an interesting finding [2-7]. Ferrets of the Hungarian shelter were feed regularly with 
chicken meat. This could be an explanation why a well known chicken pathogen, CAV, and a newly described 
member of the genus, AGV2, were detected in the feces of these animals. Similarly, food-associated acquisition 
and passive transfer through the gut could explain the detection of gyroviruses in the feces of humans and cats as 
reported in other studies [3-5, 10]. However, gyroviruses were also detected in the human blood; thus, the 
possibility that certain gyroviruses are capable of infecting a mammalian host species can not be ruled out [6-7]. 
Of note is that ferret coronaviruses were also detected in the fecal specimens by high throughput 
sequencing. Coronavirus is a common cause of diarrhoea in a variety of animal species and may induce systemic 
disease [11]. Novel gyroviruses have been already detected in diseased humans and chickens [1, 3-5] and it 
seems plausible that, similarly to CAV [1], these novel members of the genus may also induce immune 
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suppression in a different host species, such as ferrets. However, this assumption awaits supporting 
epidemiological and experimental data.  
In summary, the finding that genetically identical gyroviruses can be detected in humans and ferrets 
warrants the need for close monitoring of these newly described viruses. The causative role and the host range of 
different gyroviruses must be explored to help better understand the findings of this study.  
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Table 1 Results of the metagenomic and gyrovirus PCR analyses of ferret fecal samples. Two samples were 
taken at different dates from ferrets labelled as G8, G10 and G20. Accession number of the references and nt 
similarities of those to our sequences are indicated in the parenthesis. HGyV: human gyrovirus, AGV2: avian 
gyrovirus 2, GyV3 and GyV4: gyrovirus 3 and 4, CAV: chicken anaemia virus. HGyV/AGV2: HGyV and/or 
AGV2 sequences were detected in the sample. N.D.: not done. W: whole genome sequenced strain 
 
Table 2 Primer sequences designed for the amplification and sequencing of gyrovirus sequences of ferret fecal 
samples. Primer positions without parenthesis refer to human gyrovirus and values in the parenthesis label 
primer positions in the avian gyrovirus 2 
 
Fig. 1 Sequencing of the GC-rich non-coding region of the human gyrovirus strain G13. Panel A: Early 
termination after amplification and Sanger sequencing. Panel B: Sequences gained by PCR containing 7-deaza-
dGTP in the reaction mixtures. Panel C: Sequences after the utilization of 7-deaza-dGTP in both PCR and 
sequencing reaction mixtures 
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Abstract 
The recently described novel gyroviruses may infect chickens and/or humans; 
however, their pathogenic potential is unknown. In our metagenomic investigation, we 
detected many of the novel gyroviruses in the fecal viromes of ferrets with lymph node and 
organ enlargement. The complete genomic sequences of selected gyrovirus strains showed 
90.7-99.4% similarity to homologous reference gyrovirus strains. This study did not 
demonstrate an association between gyrovirus shedding from ferrets and the observed 
background disease; however, it provides evidence for genetic diversity among gyroviruses 
and raises the possibility that pet ferrets may transmit gyroviruses to heterologous hosts, e.g., 
humans. 
 
 
Several new members of the genus Gyrovirus (family Circoviridae) have been 
described during the past three years. Chicken anaemia virus (CAV) causes anaemia, bone 
marrow atrophy and severe immunosuppression in poultry and represents the prototype 
species within the genus. Newly described members include human gyrovirus (HGyV), avian 
gyrovirus 2 (AGV2), GyV3, GyV4, GyV5 and GyV6 [1-5]. It is of interest that some of these 
new gyrovirus types have been identified in human skin (HGyV), blood (HGyV) and stool 
(all gyroviruses) specimens, although an etiologic role of these viruses in human disease has 
not been demonstrated [1-7]. Furthermore, in addition to CAV, AGV2, HGyV and GyV4 
have also been detected in chicken serum, meat and skin [1-3]. 
 In this study, 23 diarrheic stool specimens were collected from 20 pet ferrets (Mustela 
putorius furo) housed in a shelter. The animals had a background disease characterized by 
lymph node and spleen enlargement. The majority of samples (21 samples of 18 ferrets) were 
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subjected to viral metagenomics. In brief, the genomic RNA was extracted using a Viral RNA 
Mini Kit (QIAGEN) according to the manufacturer's instructions. The RNA sample was 
denatured at 97°C for 5 min in the presence of 10 µM random hexamer tailed by a common 
PCR primer sequence [8]. A reverse transcription reaction mixture containing 400 µM 
dNTPs, 1X AMV RT buffer and 1 U AMV reverse transcriptase (Promega) was added and 
then incubated at 42°C for 45 min. Five microliters of cDNA was amplified in a final reaction 
volume of 50 µl including 500 µM PCR primers, 200 µM dNTP mixture, 1.5 mM MgCl2, 1X 
Taq DNA polymerase buffer and 0.5 U Taq DNA polymerase (Thermo Scientific). The 
reaction conditions consisted of a denaturation step at 95°C for 3 min, 40 cycles of 
amplification (95°C for 30 s, 48°C for 30 s, 72°C for 2 min) and a final extension step at 72°C 
for 8 min. 
Enzymatic fragmentation was carried out from 100 ng of the amplified cDNA using 
the reagents of the NEBNext® Fast DNA Fragmentation & Library Prep Set for Ion 
Torrent™ kit (New England Biolabs) according to the manufacturer's instructions. Adaptor 
ligation was performed using reagents from the same kit, whereas barcoded adaptors were 
retrieved from the Ion XpressTM Barcode Adapters (Life Technologies). The barcoded 
library DNA samples were column extracted using a Gel/PCR DNA Fragments Extraction Kit 
(Geneaid) and then run on a 2% precast gel (Life Technologies). Products between 300 and 
350 bp were used directly without further purification in the PCR mixture of the NEBNextR 
Fast DNA Fragmentation & Library Prep Set for Ion Torrent
TM
 kit (NEB). Library DNA was 
subsequently amplified (initial denaturation at 98° C for 30 s, followed by 12 amplification 
cycles of 98°C for 10 s, 58°C for 30 s and 72°C for 30 s, and termination at 72°C for 5 min). 
The amplified library DNA was purified using a Gel/PCR DNA Fragments Extraction Kit 
(Geneaid) and was quantified fluorimetrically on a Qubit® 2.0 fluorometer using the Qubit® 
dsDNA BR Assay Kit (Life Technologies). Approximately equimolar aliquots of the 
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individually barcoded products were mixed in a single tube, and this library mixture was used 
in subsequent emulsion PCR according to the manufacturer's protocol using an Ion PGM 
Template Kit on an OneTouch v2 instrument. Enrichment of the templated beads (on an Ion 
One Touch ES machine) and further steps of pre-sequencing set-up were performed according 
to the 200 bp sequencing protocol of the manufacturer (Life Technologies). The sequencing 
protocol recommended for the Ion PGM
TM
 Sequencing Kit on a 316 chip was strictly 
followed. Raw sequence data were mapped onto reference sequences from the GenBank 
database using CLC Bio software (http://www.clcbio.com/). Sequence alignments and 
distance matrixes using the p-distance algorithm were prepared in MEGA 6 using the 
MUSCLE program [9]. 
Viral metagenomics generated an average of 67,737 sequence reads (range, 36,337-
87,870) from each barcoded cDNA library. The metagenomic assemblage identified 
coronaviruses and a great diversity of gyroviruses (including HGyV, AGV2, GyV3, GyV4 
and CAV; Table 1) in 50% (9/18) and 44% (8/18) of the animals, respectively. Although 
detection of chicken-origin gyroviruses (such as CAV and AGV2) in the fecal specimens was 
not surprising, the identification of putative human gyroviruses in the ferret fecal virome was 
somewhat unexpected; therefore, we systematically screened by PCR all available ferret stool 
samples for different gyroviruses, including those that were previously found exclusively in 
humans, in chickens, or both. 
The PCR primers targeted the VP1 gene of HGyV/AGV2, GyV3, GyV4 and CAV, 
and the VP2 genomic region of HGyV/AGV2 and GyV3 [3-4]. When the results of targeted 
PCR and metagenomic analysis were merged, the stool samples of 14 animals were found to 
contain traces of gyrovirus genomic DNA. The main type was HGyV (identified in 13 of 14 
animals). Eleven animals shed a mixture of gyroviruses; CAV was a commonly seen strain in 
specimens containing multiple gyroviruses (11/11), whereas GyV3 was amplified by PCR 
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from two, and GyV4 and AGV2 from one ferret each. Interestingly, genomic DNA of another 
GyV3 and three GyV4 strains was identified by viral metagenomics in specimens that were 
negative by gene-specific PCR. Sequence variation in the primer-binding region provided a 
possible explanation for PCR failures in some instances and suggested limited sensitivity of 
published GyV3- and GyV4-specific PCR primers [3-4].  
Subsequently, PCR primers were designed for the amplification of representative full-
length gyrovirus genomes. PCR assays with back-to-back primers were performed in a 
reaction volume of 20 µl containing 250 µM each dNTP, 250 nM each primer, 1X Phusion 
Green HF Buffer and 0.3 U Phusion DNA polymerase (Thermo Scientific). Amplification 
conditions were as follows: denaturation at 98 ºC for 30 s, 40 cycles of 98 ºC for 10s, 53 or 59 
ºC for 30s (for GyV4 and HGyV/AGV2, respectively) and 72 ºC for 90 s, and a final 
extension at 72 ºC for 10 min. Sequencing of the amplified genomes was performed using the 
‘primer-walking’ approach and Sanger sequencing using an ABI PRISM® 3100-Avant 
Genetic Analyzer and a BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies). 
Primers used for amplification and sequencing are presented in Table 2. The full-length 
genomes of five ferret-origin gyrovirus strains (three HGyV, one AGV2, one GyV4) were 
determined, and three representative genome sequences were deposited in the GenBank 
database (accession numbers: KJ452213 for AGV2 G17, KJ452214 for HGyV G13 and 
KJ452215 for GyV4 G14). Short fragments (~15-25 nucleotides in length) in the non-coding 
region could be sequenced only by a modified sequencing protocol due to the high GC 
content of the predicted hairpin structure just downstream the VP1, although back-to-back 
and other primers designed to amplify smaller products (559 bp for HGyV and AGV2 and 
599 bp for Gyv4) spanning the putative hairpin structure worked well in our hands. 
Sequencing issues concerning these non-coding fragments even after cloning has been 
reported by other research groups [5]. In the present study, PCR assays and sequencing 
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reactions in the presence of different concentrations of DMSO, betaine and Q-solution 
(QIAGEN) were tested, but early termination of the sequencing reaction was always observed 
(Fig. 1, panel A). A modified PCR using 7-deaza-dGTP (New England Biolabs) in a reaction 
volume of 20 µl contained 250 nM primers specific for the GC-rich region (Table 1), 25 µM 
dATP, dCTP, dTTP and 7-deaza-dGTP (New England Biolabs), 1X DreamTaq Green Buffer 
and 0.5 U DreamTaq DNA Polymerase (Thermo Scientific). The cycling profile was as 
follows: denaturation at 95 ºC for 3 min, 40 cycles of 95 ºC for 30 s, 54 ºC for 30 s and 72 ºC 
for 1 min, and a final extension step at 72 ºC for 10 min. As in the previous attempts, these 
sequences were also terminated before reaching the GC-rich region or yielded ambiguous 
sequencing results (Fig. 1, panel B). High-quality sequences for the hairpin region were only 
obtained when 2.5-5 µM 7-deaza-dGTP was included in both the PCR and sequencing 
reaction mixtures (Fig. 1, panel C). As a result, alternating reiterations of homo-G-polymer 
and homo-C-polymer regions, 61 nt (HGyV/AGV2) and 42 nt (GyV4) in length, were 
revealed in the missing genomic region. 
The three HGyV genomes were 2375 nt long; the genome sequences were identical to 
each other and were closely related (94.5%) to the AGV2 G17 strain, which has a genome 
length of 2378 nt. The complete genomic sequence of Hungarian HGyV G13 was 61 nt longer 
than that of the reference HGyV (accession number: FR823283), which lacked the GC-rich 
region identified in our HGyV and AGV2 genomes as well as in the AGV2 genomes 
deposited in the GenBank database (accession numbers: JQ690763, HM590588). The 
complete genomes of HGyV G13 and AGV2 G17 showed 99.4% and 94.2-95.9% similarity 
along the overlapping regions of the whole genomes of homologous reference strains HGyV 
and AGV2, respectively. Although the genome of the G17 strain had a codon insertion 
affecting the potential VP2 and VP3 proteins, the overall genome size and structure of the 
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non-coding region were comparable with those of the G13 and the AGV2 reference genome 
sequences. 
The full-length genome of the Hungarian GyV4 strain, G14, was 2028 nt long, i.e., six 
bases shorter than the only GyV4 reference genome sequence available in GenBank 
(accession number: JX310702). These two genome sequences showed 90.7% nt similarity to 
each other. The nt and amino acid similarities along the VP1 and VP2 regions showed an 
inverse pattern (86.7% and 94% nt and 92.6% and 88.9% aa similarity, respectively) to the 
reference sequence. This lower sequence similarity between GyV4 strains suggests a greater 
diversity within this group of gyroviruses than seen among HGyV and AGV2 strains, which 
are believed to be minor sequence variants of the same virus [3].  
PCR results obtained using diagnostic primers were systematically confirmed by 
sequencing of the amplicons. Briefly, the short HGyV sequences (251-429 nt long) amplified 
using the diagnostic primers [3-4] shared 100% identity among themselves. A 392-nt-long 
stretch [3-4] in two GyV3 strains shared 98% nt sequence identity with each other and 99% to 
the reference sequence (accession number: JQ308210). The only GyV4 sequence (239 nt 
long) amplified using diagnostic primers [3] showed 93.3% and 94.6% nt similarity to our 
G14 strain and the reference GyV4 strain, respectively. CAV strains showed 99-100% 
similarity to each other and 100% similarity to the reference strains found in GenBank. No 
traces of GyV5 and GyV6 were observed in the metagenomic analyses; thus, the study was 
not extended to the examination of these novel gyroviruses. Unfortunately, determination of 
whole genomic sequences of additional gyroviruses was not possible because of the small 
amount of stool samples and/or poor amplification results. 
 The identification of genetically related, practically indistinguishable, gyroviruses in 
the fecal viromes of humans and ferrets is an interesting finding [2-7]. Ferrets in the 
Hungarian shelter were feed regularly with chicken meat. This could be an explanation for 
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why a well-known chicken pathogen, CAV, and a newly described member of the genus, 
AGV2, were detected in the feces of these animals. Similarly, food-associated acquisition and 
passive transfer through the gut could explain the detection of gyroviruses in the feces of 
humans and cats as reported in other studies [3-5, 10]. However, gyroviruses were also 
detected in human blood, and thus the possibility that certain gyroviruses are capable of 
infecting a mammalian host cannot be ruled out [6-7]. 
It is worth noting that ferret coronaviruses have also been detected in fecal specimens 
by high-throughput sequencing. Coronaviruses are a common cause of diarrhoea in a variety 
of animal species and may induce systemic disease [11]. Novel gyroviruses have already been 
detected in diseased humans and chickens [1, 3-5], and it seems plausible that, like CAV [1], 
these novel members of the genus may also induce immune suppression in a different host 
species, such as ferrets. However, this assumption awaits supporting epidemiological and 
experimental data.  
In summary, the finding that genetically identical gyroviruses can be detected in 
humans and ferrets warrants close monitoring of these newly described viruses. The causative 
role and the host range of different gyroviruses must be explored to help better understand the 
findings of this study.  
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Table 1 Results of metagenomic and gyrovirus PCR analyses of ferret fecal samples. Two 
samples were taken at different dates from ferrets labelled as G8, G10 and G20. Accession 
numbers of the references and nt similarities of those to our sequences are indicated in 
parentheses. HGyV, human gyrovirus; AGV2, avian gyrovirus 2; GyV3 and GyV4, gyrovirus 
3 and 4; CAV, chicken anaemia virus. "HGyV/AGV2" indicates that HGyV and/or AGV2 
sequences were detected in the sample. N.D., not done. W, whole genome sequence  
 
Table 2 Primer sequences designed for the amplification and sequencing of gyrovirus 
sequences from ferret fecal samples. Primer positions without parentheses refer to human 
gyrovirus, and values in parentheses indicate primer positions in avian gyrovirus 2 
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Fig. 1 Sequencing of the GC-rich non-coding region of the human gyrovirus strain G13. Panel 
A: early termination after amplification and Sanger sequencing. Panel B: sequences 
determined using PCR with 7-deaza-dGTP in the reaction mixtures. Panel C: sequences after 
the utilization of 7-deaza-dGTP in both PCR and sequencing reaction mixtures 
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Sample 
name 
Metagenomic analysis PCR 
HGyV/AGV2 GyV3 GyV4 CAV HGyV/AGV2 GyV3 GyV4 CAV 
G1 + - + - + (FR823283, 100%) - - + (FJ360724, 100%) 
G2 N.D. + (FR823283, 100%) - - + (FJ360724, 100%) 
G3 + - + + + (FR823283, 100%) - - + (no sequence) 
G4 - - - - - - - - 
G5 - - - - - - - - 
G6 N.D. - - - - 
G7 - - - - + (FR823283, 100%) - - - 
G8 - - - - - - - - 
G8A - - - - + (FR823283, 100%) - - + (no sequence) 
G9 - - - - + (FR823283, 100%) + (JQ308210, 99.0%) - + (FJ360725, 100%) 
G10 - - - - - - - - 
G10A - - - - - - - - 
G11 - - - - + (FR823283, 100%) + (JQ308210, 99.0%) - + (no sequence) 
G12 - - - - - - - - 
G13 + - - - W (FR823283, 99.4%) - + (JX310702, 94.6%) + (FJ360724, 100%) 
G14 + - W (JX310702, 90.7%) - W (FR823283, 99.4%) - - + (FJ360724, 100%) 
G15 - - - - + (FR823283, 100%) - - + (FJ360725, 100%) 
G16 - - - - - - - - 
G17 
+ - - - 
W (JQ690763, 95.9%, 
HM590588, 94.2%) 
- - - 
G18 + - - - + (FR823283, 100%) - - + (FJ360724, 100%) 
G19 + + - - W (FR823283, 99.4%) - - + (FJ360724, 100%) 
G20 + - - - + (FR823283, 100%) - - - 
G20A - - - - - - - - 
Positive 
samples 
8/21 
(38.1%) 
1/21 
(4.8%) 
3/21 
(14.3%) 
1/21 
(4.8%) 
14/23 
(60.9%) 
2/23 
(8.7%) 
1/23 
(4,3%) 
11/23 
(55%) 
Positive 
animals 
8/18 
(44.4%) 
1/18 
(5.6%) 
3/18 
(16.7%) 
1/18 
(5.6%) 
14/20 
(70%) 
2/20 
(10%) 
1/20 
(5%) 
11/20 
(47.8%) 
 
Table 1
Primer name 
Position 
5’-3’ primer sequence Function 
human gyrovirus/avian gyrovirus 2 
GGyV1-F1 
203-231 
AGTAAACTGAGACTCATACCGGTACAGGG back-to-back PCR, sequencing 
GGyV1-R1 
202-172 
TACATATCGTTGGTTACCACGCCTTGTG 
back-to-back PCR, sequencing, modified 
PCR of GC-rich region 
GGyV1-F2 
1009-1031 
(1012-1034) 
ACGATGGCACTGGAGACACAGAC back-to-back PCR, sequencing 
GGyV1-R2 
1008-986 
(1011-989) 
CCTCTGTGGTAGAAGCCAAAGCG back-to-back PCR, sequencing 
GGyV1-F3 
1098-1124 
(1101-1127) 
GCGTTAAGAGGAGGATCTTCAACCCAC back-to-back PCR, sequencing 
GGyV1-R3 
1097-1074 
(1100-1077) 
GGCGATCAAAGGATCTTCTACGCG back-to-back PCR, sequencing 
GGyV1-F4 
1494-1519 
(1497-1522) 
GAGCACCTGGCAGATTTTACAATGCC back-to-back PCR, sequencing 
GGyV1-R4 
1493-1472 
(1496-1475) 
TAGGGTGCATCACCAGGAGAGC back-to-back PCR, sequencing 
GGyV1-F/1 
685-710  
GAGATCCAAATTGGTATCGGGTCAAC sequencing 
GGyV1-F/2 
1683-1706 
(1686-1709) 
TAGAGGGCTTCCCAGTTAAAGGTG sequencing 
GGyV1-F/3 
1946-1968 
(1949-1971) 
GGTGCACCCTGGTCATTTCCTAG  sequencing 
GGyV1-F/4 
2039-2060 
(2042-2063) 
CGACGGTGGTTAACACTTGTGC 
sequencing, modified PCR of GC-rich 
region 
GGyV1-R/1 
539-518  
AAGTTGCCCCTCTTGCCTAAGC sequencing 
GGyV1-R/2 
662-639  
GGAGACGAACTTGTTGGATGCTCG sequencing 
gyrovirus 4 
GGyV4-F 
(974-992) 
TCAGATTCAGACGGAGACC back-to-back primers 
GGyV4-R 
(973-954) 
CCATTCCACAAAACTGTCCC back-to-back primers 
GGyV4-F/1 
1446-1469 
TGCAAATGGAACTAGGCCGACAG sequencing 
GGyV4-F/2 
277-299 
ATGGCAGGGTACTTATTGCCGTG sequencing 
GGyV4-F/3 
1835-1862 
TCGGTACATTGTTTCTCGCGGAATTTAG 
sequencing, modified PCR of GC-rich 
region 
GGyV4-R/1 
538-517 
ACTAAAGCGATGGTCAGGGCTG sequencing 
GGyV4-R/2 
405-384 
AGCAAAAATTCACTGCCCCGAG 
sequencing, modified PCR of GC-rich 
region 
GGyV4-R/3 
1256-1232 
TCAGCCTGTCCAGACTGATATACGG sequencing 
 
Table 2
